295 related articles for article (PubMed ID: 34972811)
1. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.
Lawson-Tovey S; Machado PM; Strangfeld A; Mateus E; Gossec L; Carmona L; Raffeiner B; Bulina I; Clemente D; Zepa J; Rodrigues AM; Mariette X; Hyrich KL;
RMD Open; 2022 Jul; 8(2):. PubMed ID: 35908834
[TBL] [Abstract][Full Text] [Related]
3. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
Spinelli FR; Favalli EG; Garufi C; Cornalba M; Colafrancesco S; Conti F; Caporali R
Arthritis Res Ther; 2022 Jan; 24(1):21. PubMed ID: 35016701
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of inactivated SARS-CoV-2 vaccination in COVID-19-associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real-world retrospective observational study.
Liu S; Jin Z; Feng X; Da Z; Tang Y; Hu H; Wang D; Sun L
Int J Rheum Dis; 2024 May; 27(5):e15166. PubMed ID: 38720417
[TBL] [Abstract][Full Text] [Related]
5. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.
Kroon FPB; Najm A; Alunno A; Schoones JW; Landewé RBM; Machado PM; Navarro-Compán V
Ann Rheum Dis; 2022 Mar; 81(3):422-432. PubMed ID: 34876462
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.
Farisogullari B; Lawson-Tovey S; Hyrich KL; Gossec L; Carmona L; Strangfeld A; Mateus EF; Schäfer M; Rodrigues A; Hachulla E; Gomez-Puerta JA; Mosca M; Durez P; Trefond L; Goulenok T; Cornalba M; Stenova E; Bulina I; Strakova E; Zepa J; Roux N; Brocq O; Veillard E; Raffeiner B; Burmester GR; Mariette X; Machado PM;
Ann Rheum Dis; 2024 May; ():. PubMed ID: 38816065
[TBL] [Abstract][Full Text] [Related]
7. Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
Connolly CM; Ruddy JA; Boyarsky BJ; Barbur I; Werbel WA; Geetha D; Garonzik-Wang JM; Segev DL; Christopher-Stine L; Paik JJ
Arthritis Rheumatol; 2022 Jan; 74(1):28-32. PubMed ID: 34346185
[TBL] [Abstract][Full Text] [Related]
8. Correspondence on "Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry" by Machado
Bourguiba R; Delplanque M; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S;
Ann Rheum Dis; 2023 Dec; 82(12):e228. PubMed ID: 35817471
[No Abstract] [Full Text] [Related]
9. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across-sectional study.
Zhang Y; Xu P; Huang J; Hu Z
Int J Rheum Dis; 2024 Apr; 27(4):e15150. PubMed ID: 38661306
[TBL] [Abstract][Full Text] [Related]
10. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
[TBL] [Abstract][Full Text] [Related]
11. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
Sattui SE; Liew JW; Kennedy K; Sirotich E; Putman M; Moni TT; Akpabio A; Alpízar-Rodríguez D; Berenbaum F; Bulina I; Conway R; Singh AD; Duff E; Durrant KL; Gheita TA; Hill CL; Howard RA; Hoyer BF; Hsieh E; El Kibbi L; Kilian A; Kim AH; Liew DFL; Lo C; Miller B; Mingolla S; Nudel M; Palmerlee CA; Singh JA; Singh N; Ugarte-Gil MF; Wallace J; Young KJ; Bhana S; Costello W; Grainger R; Machado PM; Robinson PC; Sufka P; Wallace ZS; Yazdany J; Harrison C; Larché M; Levine M; Foster G; Thabane L; Rider LG; Hausmann JS; Simard JF; Sparks JA
RMD Open; 2021 Sep; 7(3):. PubMed ID: 34493645
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany.
Sengler C; Eulert S; Minden K; Niewerth M; Horneff G; Kuemmerle-Deschner J; Siemer C; Berendes R; Girschick H; Hühn R; Borte M; Hospach A; Emminger W; Armann J; Klein A; Kallinich T
RMD Open; 2021 Jul; 7(2):. PubMed ID: 34312307
[TBL] [Abstract][Full Text] [Related]
13. SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.
Ko T; Dendle C; Woolley I; Morand E; Antony A
Hum Vaccin Immunother; 2021 Nov; 17(11):4048-4056. PubMed ID: 34357827
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
Liew J; Gianfrancesco M; Harrison C; Izadi Z; Rush S; Lawson-Tovey S; Jacobsohn L; Ja C; Hyrich KL; Gossec L; Strangfeld A; Carmona L; Schäfer M; Frãzao-Mateus E; Bulina I; Stafford F; Tufan A; Graver C; Yardımcı GK; Zepa J; Al Emadi S; Cook C; Abutiban F; Dey D; Katigbak G; Kaufman L; Kowalski E; Martínez-Martínez MU; Patel NJ; Reyes-Cordero G; Salido E; Smith E; Snow D; Sparks J; Wise L; Bhana S; Gore-Massy M; Grainger R; Hausmann J; Sirotich E; Sufka P; Wallace Z; Machado PM; Robinson PC; Yazdany J
RMD Open; 2022 Apr; 8(1):. PubMed ID: 35387864
[TBL] [Abstract][Full Text] [Related]
15. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey.
Cherian S; Paul A; Ahmed S; Alias B; Manoj M; Santhosh AK; Varghese DR; Krishnan N; Shenoy P
Rheumatol Int; 2021 Aug; 41(8):1441-1445. PubMed ID: 34142203
[TBL] [Abstract][Full Text] [Related]
16. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
Landewé RBM; Kroon FPB; Alunno A; Najm A; Bijlsma JW; Burmester GR; Caporali R; Combe B; Conway R; Curtis JR; Elkayam O; Gossec L; Heijstek MW; Haupt L; Iagnocco A; Isaacs JD; Juhász IÁ; Makri S; Mariette X; McInnes IB; Mehta P; Mueller-Ladner U; Schulze-Koops H; Smolen JS; Wiek D; Winthrop KL; Navarro-Compán V; Machado PM
Ann Rheum Dis; 2022 Dec; 81(12):1628-1639. PubMed ID: 35197264
[TBL] [Abstract][Full Text] [Related]
17. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.
Curtis JR; Johnson SR; Anthony DD; Arasaratnam RJ; Baden LR; Bass AR; Calabrese C; Gravallese EM; Harpaz R; Kroger A; Sadun RE; Turner AS; Williams EA; Mikuls TR
Arthritis Rheumatol; 2021 Aug; 73(8):e30-e45. PubMed ID: 34128356
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
Liao HT; Tung HY; Chou CT; Tsai HC; Yen YN; Tsai CY
Scand J Rheumatol; 2022 Nov; 51(6):500-505. PubMed ID: 35638589
[TBL] [Abstract][Full Text] [Related]
19. CVAPPS: A Cross-Sectional Study of SARS-CoV-2 Vaccine Acceptance, Perceptions, and Post-Vaccination Side Effects among Rheumatic Disease Patients in Kuwait.
Baroun F; Albasri A; Abutiban F; Alhajeri H
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992250
[No Abstract] [Full Text] [Related]
20. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine.
Ozdede A; Guner S; Ozcifci G; Yurttas B; Toker Dincer Z; Atli Z; Uygunoğlu U; Durmaz E; Uçar D; Uğurlu S; Saip S; Tabak F; Hamuryudan V; Seyahi E
Rheumatol Int; 2022 Jun; 42(6):973-987. PubMed ID: 35376962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]